Your investment thesis is "FDA didn't approve the first time, it's much more likely the second time", and "we have x many indications, one is likely to get through".
I don't think I need to explain the flaws in those assumptions.
The stem cell company I put a small amount of money into ages ago was OCC, since it seems y'all are extremely curious. Bit of a punt.
No amount of proof or failure will change your mind about MSB's prospects. But just be wary when telling potential investors "all you need to do is wait". In 2 years time I forecast MSB will either be successful with a product or no longer a viable company - I doubt there is an in between.
IMO
Ann: Update on Novartis Agreement, page-834
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |